Philadelphia chromosome–like acute lymphoblastic leukemia
Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), also referred to as
BCR-ABL1–like ALL, is a high-risk subset with a gene expression profile that shares …
BCR-ABL1–like ALL, is a high-risk subset with a gene expression profile that shares …
High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults
KG Roberts, Z Gu, D Payne-Turner… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Philadelphia chromosome (Ph)–like acute lymphoblastic leukemia (ALL) is a high-
risk subtype of childhood ALL characterized by kinase-activating alterations that are …
risk subtype of childhood ALL characterized by kinase-activating alterations that are …
Ph-like acute lymphoblastic leukemia
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a newly
identified high-risk (HR) B-lineage ALL subtype, accounting for∼ 15% of children with …
identified high-risk (HR) B-lineage ALL subtype, accounting for∼ 15% of children with …
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL
KG Roberts, YL Yang, D Payne-Turner, W Lin… - Blood …, 2017 - ashpublications.org
New therapies for Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like
ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by …
ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by …
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner… - New England journal …, 2014 - Mass Medical Soc
Background Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL …
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL …
Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia
RC Harvey, SK Tasian - Blood advances, 2020 - ashpublications.org
Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts
for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and …
for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and …
Philadelphia chromosome–like acute lymphoblastic leukemia
CH Pui, KG Roberts, JJ Yang, CG Mullighan - Clinical Lymphoma Myeloma …, 2017 - Elsevier
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a recently
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
KG Roberts, SC Reshmi, RC Harvey… - Blood, The Journal …, 2018 - ashpublications.org
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL; BCR-ABL1–like
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
Philadelphia chromosome‐positive acute lymphoblastic leukemia: Current treatment and future perspectives
HJ Lee, JE Thompson, ES Wang, M Wetzler - Cancer, 2011 - Wiley Online Library
Abstract The Philadelphia chromosome (Ph) is the most common cytogenetic abnormality
associated with adult acute lymphoblastic leukemia (ALL). Before the advent of tyrosine …
associated with adult acute lymphoblastic leukemia (ALL). Before the advent of tyrosine …
High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL
Treatment of patients with Philadelphia chromosome-positive B-cell acute lymphoblastic
leukemia (Ph+ B-ALL) with tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib …
leukemia (Ph+ B-ALL) with tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib …